Archives of Critical Care Medicine

Published by: Kowsar

The Correlation Between the Plasma Level of Endothelin-1 and Pulmonary Artery Pressure in Patients on Hemodialysis Due to End-Stage Renal Disease

Sasan Tavana 1 , Hasan Argani 1 , Mohammad Khani 2 , Maryam Shariatmadari 1 and Ali Dabbagh 3 , *
Authors Information
1 Department of Internal Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Cardiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Anesthesiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Critical Care Medicine: January 28, 2015, 1 (1); e520
  • Published Online: August 28, 2014
  • Article Type: Brief Report
  • Received: January 2, 2014
  • Revised: March 7, 2014
  • Accepted: June 3, 2014
  • DOI: 10.5812/accm.520

To Cite: Tavana S, Argani H, Khani M, Shariatmadari M, Dabbagh A. et al. The Correlation Between the Plasma Level of Endothelin-1 and Pulmonary Artery Pressure in Patients on Hemodialysis Due to End-Stage Renal Disease , Arch Crit Care Med. 2015 ;1(1):e520. doi: 10.5812/accm.520.

Abstract
Copyright © 2015, Kowsar Corp.; Published by Kowsar.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Rosenblum WD. Pulmonary arterial hypertension: pathobiology, diagnosis, treatment, and emerging therapies. Cardiol Rev. 2010; 18(2): 58-63[DOI][PubMed]
  • 2. Abman SH. Pulmonary hypertension in children: a historical overview. Pediatr Crit Care Med. 2010; 11(2 Suppl)-9[DOI][PubMed]
  • 3. Oishi P, Datar SA, Fineman JR. Pediatric pulmonary arterial hypertension: current and emerging therapeutic options. Expert Opin Pharmacother. 2011; 12(12): 1845-64[DOI][PubMed]
  • 4. Ventetuolo CE, Kawut SM, Lederer DJ. Plasma endothelin-1 and vascular endothelial growth factor levels and their relationship to hemodynamics in idiopathic pulmonary fibrosis. Respiration. 2012; 84(4): 299-305[DOI][PubMed]
  • 5. Yu J, Taylor L, Wilson J, Comhair S, Erzurum S, Polgar P. Altered expression and signal transduction of endothelin-1 receptors in heritable and idiopathic pulmonary arterial hypertension. J Cell Physiol. 2013; 228(2): 322-9[DOI][PubMed]
  • 6. Maron BA, Zhang YY, White K, Chan SY, Handy DE, Mahoney CE, et al. Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension. Circulation. 2012; 126(8): 963-74[DOI][PubMed]
  • 7. Rich S. Right ventricular adaptation and maladaptation in chronic pulmonary arterial hypertension. Cardiol Clin. 2012; 30(2): 257-69[DOI][PubMed]
  • 8. Morin C, Fortin S, Rousseau E. Docosahexaenoic acid monoacylglyceride decreases endothelin-1 induced Ca(2+) sensitivity and proliferation in human pulmonary arteries. Am J Hypertens. 2012; 25(7): 756-63[DOI][PubMed]
  • 9. Huang H, Zhang P, Wang Z, Tang F, Jiang Z. Activation of endothelin-1 receptor signaling pathways is associated with neointima formation, neoangiogenesis and irreversible pulmonary artery hypertension in patients with congenital heart disease. Circ J. 2011; 75(6): 1463-71[PubMed]
  • 10. Shao D, Park JE, Wort SJ. The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension. Pharmacol Res. 2011; 63(6): 504-11[DOI][PubMed]
  • 11. Pan P, Zhang X, Qian H, Shi W, Wang J, Bo Y, et al. Effects of electro-acupuncture on endothelium-derived endothelin-1 and endothelial nitric oxide synthase of rats with hypoxia-induced pulmonary hypertension. Exp Biol Med (Maywood). 2010; 235(5): 642-8[DOI][PubMed]
  • 12. Hamidi SA, Lin RZ, Szema AM, Lyubsky S, Jiang YP, Said SI. VIP and endothelin receptor antagonist: an effective combination against experimental pulmonary arterial hypertension. Respir Res. 2011; 12: 141[DOI][PubMed]
  • 13. Channick RN, Sitbon O, Barst RJ, Manes A, Rubin LJ. Endothelin receptor antagonists in pulmonary arterial hypertension. J Am Coll Cardiol. 2004; 43(12 Suppl S): 62S-7S[DOI][PubMed]
  • 14. Dupuis J, Jasmin JF, Prie S, Cernacek P. Importance of local production of endothelin-1 and of the ET(B)Receptor in the regulation of pulmonary vascular tone. Pulm Pharmacol Ther. 2000; 13(3): 135-40[DOI][PubMed]
  • 15. Yuan P, Wu WH, Gao L, Zheng ZQ, Liu D, Mei HY, et al. Oestradiol ameliorates monocrotaline pulmonary hypertension via NO, prostacyclin and endothelin-1 pathways. Eur Respir J. 2013; 41(5): 1116-25[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments